Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 132 participants.

Also called NCT05294887

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 132 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05294887
  • EudraCT 2020-004717-12
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany, Switzerland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05294887. Randomized; quadruple masking; primary purpose treatment. Start 2022-03-04 (actual); primary completion 2024-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease
Acronym
EXAMINE-CAD
Condition
Coronary Microvascular Dysfunction
Condition
Microvascular Angina
Condition
Vasospasm, Coronary
Condition
Vasospastic Angina
Condition
Prinzmetal Angina
Intervention (Drug)
Bisoprolol
Intervention (Drug)
Diltiazem
Intervention (Drug)
Placebo
Lead sponsor
Charite University, Berlin, Germany (class: other)
Collaborator
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) (class: other)

Record details

Record id
cardio:ct-nct05294887
Content hash
2655455662d1e2a6d895f884a7646a17fe21c4812af665cd070f0e2d6f7260b6